Skip to main content
SURGICAL INNOVATIONS GROUP PLC logo

SURGICAL INNOVATIONS GROUP PLC — Investor Relations & Filings

Ticker · SUN ISIN · GB0004016704 LEI · 2138004GHGUH3HUZE156 IL Manufacturing
Open in API
Filings indexed 277 across all filing types
Latest filing 2021-02-15 Regulatory Filings
Country GB United Kingdom
Listing IL SUN

About SURGICAL INNOVATIONS GROUP PLC

https://www.surgicalinnovations.com/

Surgical Innovations Group PLC designs, develops, manufactures, and distributes medical devices for minimally invasive surgery (MIS). The company specializes in creating sustainable and innovative solutions that aim to reduce the environmental impact of surgical procedures. A core part of its portfolio is the "Resposable®" technology, which integrates reusable and disposable components to offer clinically effective and environmentally conscious alternatives to single-use instruments. In addition to its branded products, the group provides original equipment manufacturing (OEM) services, engineering, and manufacturing for other medical device companies. The focus is on providing high-quality, accessible products for healthcare professionals performing keyhole surgery.

Recent filings

Filing Released Lang Actions
5-year USA distribution agreement
Regulatory Filings Classification · 98% confidence The document begins with 'RNS Number : 0224P' and contains information typical of a regulatory news service announcement, including company details, a date (15 February 2021), and an announcement about a business event (a 5-year USA distribution agreement). The footer explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' This strongly indicates a general regulatory announcement that doesn't fit the more specific categories like 10-K, ER, or DIV. Since it is a general regulatory announcement provided via RNS, the most appropriate classification is Regulatory Filings (RNS), which serves as the fallback for miscellaneous regulatory news.
2021-02-15 English
Launch of the Green Surgery Challenge
Environmental & Social Information Classification · 99% confidence The document is identified by the header 'RNS Number' and contains a date (09 February 2021) and company information, typical of a regulatory news service announcement. The content describes the company's sponsorship and involvement in the 'Green Surgery Challenge 2021', which is an operational update and partnership announcement, not a formal financial report (like 10-K or IR), a specific voting result (DVA), or a management change (MANG). It is a general announcement disseminated via the RNS system. Since it is a specific operational/partnership announcement that doesn't fit the other specific categories (like DIV, CAP, ER, etc.), the most appropriate classification is the general regulatory announcement category, RNS, as it is explicitly distributed via RNS and marked as non-regulatory press release distribution service ('Reach').
2021-02-09 English
Distalmotion’s Dexter Robot receives CE Mark
Regulatory Filings Classification · 100% confidence The document is identified by the RNS Number '9916K' and contains a headline announcing a business development ('Distalmotion's Dexter Robot receives CE Mark') and subsequent commentary from company executives. It is structured like a press release distributed via the RNS system, which is the London Stock Exchange's regulatory news service. This type of announcement, which is not a formal financial report (like 10-K or IR), a management discussion (MDA), or a specific corporate action (like DIV or SHA), falls best under the general category for regulatory announcements that do not fit elsewhere, which is 'Regulatory Filings' (RNS). The length is moderate, but the content is purely informational/news-based rather than a comprehensive financial filing.
2021-01-08 English
Future board change
Board/Management Information Classification · 98% confidence The document is an official announcement released via RNS (RNS Number : 8400K) on January 7, 2021. The core content announces a 'Future board change,' specifically that the Group Development Director intends to retire from his executive role and subsequently transition to a Non-executive Director role. This directly relates to changes in senior management/board composition. This aligns perfectly with the definition for Board/Management Information (MANG). Although it is an RNS filing, the specific content is highly targeted, making MANG the most appropriate classification over the general RNS fallback.
2021-01-07 English
Trading update
Earnings Release Classification · 99% confidence The document is titled 'Trading update' and provides an update on current trading for the financial year ending 31 December 2020, including revenue expectations (£6 million), margin maintenance, cash balances (£3.38m), and business outlook related to COVID-19 recovery and growth initiatives. It explicitly states that the company 'expects to release its audited results for the year ended 31 December 2020 in late March 2021.' This indicates the document is a pre-results trading update, not the full Annual Report (10-K) or the formal Earnings Release (ER) which typically contains the final figures. Since it is a comprehensive update on financial performance and outlook released outside of the main filing cycle, and it is distributed via RNS (indicated by the RNS Number and footer), it best fits the category for a general regulatory announcement or update that isn't a specific financial statement or management discussion/analysis (MDA). Given the content is a trading update, it is most closely related to an Earnings Release (ER) but is not the formal release itself. However, since it provides key financial highlights and operational status updates, it functions similarly to an ER, but the structure and context (RNS distribution, trading update language) suggest it is a regulatory announcement. In the absence of a specific 'Trading Update' code, and considering it provides key financial performance indicators before the final results, it aligns most closely with the 'Earnings Release' (ER) category, which covers initial announcements of periodical financial results (key highlights). If it were purely an announcement *about* a report, RPA would apply, but this document *is* the update itself. I will classify it as ER as it provides the key financial highlights for the period. FY 2020
2020-12-21 English
US distribution agreement signed with Adler
M&A Activity Classification · 99% confidence The document starts with an 'RNS Number' and is dated December 17, 2020. It announces a significant business event: a new nationwide distribution agreement signed with an existing US distributor, detailing the estimated value ($12m over five years) and effective date. The text explicitly states, 'This announcement contains inside information for the purposes of Article 7 of Regulation (EU) No 596/2014.' The document concludes with contact information and a standard disclaimer from RNS, the news service of the London Stock Exchange, which acts as a Primary Information Provider. This structure is characteristic of a general regulatory announcement or news release disseminated via the RNS system, rather than a specific financial report (like 10-K or IR) or a management/board change (MANG). Since it is a general regulatory announcement that doesn't fit perfectly into the other specific categories (like DIV, CAP, or DIRS), the most appropriate classification is the general regulatory filing category.
2020-12-17 English

Browse filings by year

36 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.